Clin2
NCT06349083Possibly a fitRecruiting

Psilocybin-assisted treatment for alcohol use disorder

Alcohol Use Disorder

Treatments studied

Part of Mental health clinical trials.

This study tests whether psilocybin, a psychedelic drug, combined with therapy can help people reduce or stop drinking. It aims to understand how psilocybin affects the brain and behavior in people with alcohol use disorder.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
200 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have been diagnosed with moderate or severe alcohol use disorder.
  • You have had at least 4 heavy drinking days in the past 30 days (4+ drinks for women, 5+ for men).
  • You are not currently in treatment for alcohol use disorder, or you have been in treatment for at least 3 months and plan to continue.
  • You are willing to stop drinking and avoid certain substances before and during the study.
  • You can attend all study visits, including therapy sessions and brain scans (fMRI).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06444243Not yet recruiting· Phase 2
Psilocybin therapy for alcohol use disorder

This trial tests whether a psilocybin (magic mushroom) therapy session can help people with alcohol use disorder reduce their drinking. You'll have one or two guided sessions with a therapist, plus support before and after, to see if it helps you change your drinking habits.

NCT07296094Not yet recruiting· Phase 2
Psilocybin therapy for severe alcohol use disorder

This trial tests whether a single dose of psilocybin (the active ingredient in 'magic mushrooms') combined with therapy can help people with severe alcohol use disorder reduce or stop drinking. It's for people who've recently completed detox and are ready to commit to a structured program in Boston.

Boston, Massachusetts
NCT07638553Recruiting· Phase 3
Psilocybin to prevent alcohol relapse with depression

This study tests whether psilocybin (a psychedelic compound) can help people with severe alcohol use disorder stay sober longer, especially if they also have depression. Participants receive guided psilocybin sessions alongside counseling to reduce the risk of returning to heavy drinking.

Bayonne
NCT05995769Recruiting· Phase 2
Psilocybin therapy with talk therapy for alcohol problems

This trial tests whether psilocybin (the active ingredient in magic mushrooms), given with talk therapy, can help people who want to reduce their heavy drinking. It is for people with at least moderate alcohol use disorder who are motivated to change.

Calgary, Alberta
NCT06405607Recruiting· Phase 2
Psilocybin vs Ketamine for Alcohol Use Disorder Trial

This trial tests two psychedelic-assisted therapies, psilocybin and ketamine, to see which works better for reducing heavy drinking in people with alcohol use disorder (AUD). You'll receive either drug along with counseling, and the study monitors safety closely.

Iowa City, Iowa
NCT06442423Recruiting· Phase 1
Psilocybin study for people with psychiatric symptoms

This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.

New Haven, Connecticut

Hear when a new Alcohol Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.